Biotech - Biostache

Queensland Has An Exciting New GM Cavendish Banana!!

by Daniel GiannettiBiotechnology, GMOs, Uncategorized May 7, 2024May 14, 2024No Comments

Instagram Linkedin The World’s First GM banana! Australia has recently marked a significant advancement in agricultural biotechnology with OGTR approval of its first genetically modified (GM) Cavendish banana, known as QCAV-4. This banana variety has been developed by Queensland University of Technology (QUT) and is the world’s first GM banana approved for commercial production and the …

Is GM Beer on the Horizon? Approved field trials sparks debate

by Ryan WallaceBiotechnology, GMOs May 4, 2024May 4, 2024No Comments

Will therebe GM beer in our foreseeable future? The success or failure of GM wheat and barley field trials will be the biggest indicator to this questions. But public perception of GMOs will be the ultimate decider.

Jumar and its Exciting Impact on Melbourne’s Biotech Sphere

by Harry GlaspoleBiotechnology, General, Melbourne May 1, 2024May 13, 2024No Comments

Read this article to discover more about the newest addition to Melbourne’s biotech hub, Jumar Bioincubator! We discuss who the major players and winners are in the development of Jumar.

AI Driven Biotechnology – A New Era of Digital Redundancy?

by Daniel GiannettiAI, Biotechnology April 24, 2024April 25, 20242 Comments

Linkedin Instagram The Emergence of AI in Biotechnology The integration of Artificial Intelligence (AI) across various industries has been nothing short of revolutionary and has completely transformed many different sectors. AI is helping these industries improve in efficiency, accuracy and scope. Is this the case in the field of Biotechnology? This article explores the ways …

Eppin Pharma’s Innovative Male Contraceptive…Could This Be The One?

by Sam RubaBiotechnology, Reproductive Health April 23, 2024April 24, 2024No Comments

In this article.. Eppin Pharma Inc has been developing a non-hormonal male contraceptive for the last 20 years. Last week in ‘Why Hasn’t Big Pharma Pulled Out A Male Contraceptive Pill?’, we discussed the need for a male contraceptive pill and the reasons why we haven’t seen one on the market yet. In that article, …

OPINION: Cultivated Meat has an Overreliance on Positive Coverage

by Harry GlaspoleBio-Engineering, Biotechnology, Cultivated Meat April 21, 2024April 21, 2024One Comment

Cultivated meat, grown from animal cells in controlled spaces, faces mixed public reception and media scrutiny, crucial for mainstream acceptance and success.

Big day for Aussie biotech: NSB and MSB soar

by Harry GlaspoleASX, Biotechnology, Finance April 2, 2024April 3, 2024No Comments

Two Australian stock exchange listed biotech companies, Neuroscientific Biopharmaceuticals LTD and Mesoblast LTD, have experienced upward spikes in share price as a result of positive news released over the Easter holiday.

Bio-engineered Silkworms Are Now Bulletproof Thanks To Spider Silk!

by Daniel GiannettiBio-Engineering, Biotechnology, Uncategorized March 18, 2024March 19, 2024No Comments

In this article Nature and Technology Time and time again we find the natural world beset with highly efficient solutions to a large amount of life’s challenges. Many of these exceed our current technological capabilities!In fairness to us, nature has had a significant head-start with millions of years of trial and error with which to …

Oh, Canada: Exopharm acquire Tryp Therapeutics

by Harry GlaspoleBiotechnology, Finance March 16, 2024March 19, 2024One Comment

In a move known as a reverse merger, Exopharm Ltd have acquired Canadian biotech company Tryp Therapeutics, who will occupy Exopharm’s place on the ASX.

Top 4 Biotech companies to look out for in 2024

by Daniel GiannettiBiotechnology, Finance February 26, 2024February 26, 2024One Comment

In this article.. The biotechnology industry is constantly evolving, with new companies emerging and established players making advancements every day. As we move through 2024, It’s important to recognise which companies are poised to make a significant impact. Currently, the market is leaning optimistically due to the high number of acquisitions into bopharma companies performed …